These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 11585435

  • 1. Preventive gynecologic surgery for BRCA1/2 carriers--information for decision-making.
    Quillin JM, Boardman CH, Bodurtha J, Smith T.
    Gynecol Oncol; 2001 Oct; 83(1):168-70. PubMed ID: 11585435
    [No Abstract] [Full Text] [Related]

  • 2. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.
    Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA.
    Gynecol Oncol; 2001 Feb; 80(2):176-80. PubMed ID: 11161856
    [Abstract] [Full Text] [Related]

  • 3. Complex decision-making for BRCA1/2 carriers.
    Matloff ET.
    Cancer J Sci Am; 1999 Feb; 5(5):266-8. PubMed ID: 10526666
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy.
    Powell CB.
    Gynecol Oncol; 2006 Jan; 100(1):1-2. PubMed ID: 16368438
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk of breast cancer in carriers of BRCA gene mutations.
    Birkmeyer JD, Welch HG.
    N Engl J Med; 1997 Sep 11; 337(11):787-8; author reply 789. PubMed ID: 9289638
    [No Abstract] [Full Text] [Related]

  • 9. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
    Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ.
    Gynecol Oncol; 2006 Jan 11; 100(1):58-64. PubMed ID: 16137750
    [Abstract] [Full Text] [Related]

  • 10. Risk of breast cancer in carriers of BRCA gene mutations.
    Orlando R.
    N Engl J Med; 1997 Sep 11; 337(11):787; author reply 789. PubMed ID: 9289637
    [No Abstract] [Full Text] [Related]

  • 11. Prophylactic surgery in patients with inherited risk of ovarian cancer.
    Morice P, Pautier P, Delaloge S.
    Gynecol Oncol; 2001 Nov 11; 83(2):445-7. PubMed ID: 11606116
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hereditary breast cancer.
    Robson ME, Boyd J, Borgen PI, Cody HS.
    Curr Probl Surg; 2001 Jun 11; 38(6):387-480. PubMed ID: 11375625
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
    Carcangiu ML, Peissel B, Pasini B, Spatti G, Radice P, Manoukian S.
    Am J Surg Pathol; 2006 Oct 11; 30(10):1222-30. PubMed ID: 17001151
    [Abstract] [Full Text] [Related]

  • 16. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
    Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, Demsky R, Murphy J, Rosen B, Narod SA.
    Gynecol Oncol; 2011 Apr 11; 121(1):163-8. PubMed ID: 21216453
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
    Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH.
    Obstet Gynecol; 2006 Sep 11; 108(3 Pt 1):515-20. PubMed ID: 16946209
    [Abstract] [Full Text] [Related]

  • 18. Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report.
    Rose PG, Shrigley R, Wiesner GL.
    Gynecol Oncol; 2000 May 11; 77(2):319-20. PubMed ID: 10785486
    [Abstract] [Full Text] [Related]

  • 19. Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers.
    Carcangiu ML, Radice P, Manoukian S, Spatti G, Gobbo M, Pensotti V, Crucianelli R, Pasini B.
    Int J Gynecol Pathol; 2004 Jan 11; 23(1):35-40. PubMed ID: 14668548
    [Abstract] [Full Text] [Related]

  • 20. Breast & ovarian cancer. Issues in risk assessment.
    Caro SW.
    Adv Nurse Pract; 1999 Aug 11; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.